Optimal medical management of patients with chronic ischemic heart disease.
O'Rourke
R A
RA
Division of Cardiology, Department of Medicine, University of Texas Health Science Center, San Antonio, Texas, USA.
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000787:Angina Pectoris / Q000175:diagnosis / Q000503:physiopathology / Q000628:therapy; D015906:Angioplasty, Balloon, Coronary; D002121:Calcium Channel Blockers / Q000627:therapeutic use; D002940:Circadian Rhythm; D001026:Coronary Artery Bypass; D004562:Electrocardiography; D005080:Exercise Test; D006801:Humans; D000960:Hypolipidemic Agents / Q000627:therapeutic use; D017202:Myocardial Ischemia / Q000000981:diagnostic imaging / Q000453:epidemiology / Q000503:physiopathology / Q000628:therapy*; D009566:Nitrates / Q000627:therapeutic use; D011877:Radionuclide Imaging; D018570:Risk Assessment; D012307:Risk Factors; D016277:Ventricular Function, Left
D000319:Adrenergic beta-Antagonists; D002121:Calcium Channel Blockers; D000960:Hypolipidemic Agents; D009566:Nitrates